Nivolumab for relapsed or refractory classical Hodgkin lymphoma after autologous haematopoietic cell transplantation: Extended follow-up of the phase 2 multi-cohort CheckMate 205 study Meeting Abstract
| Authors: | Collins, G.; Armand, P.; Engert, A.; Younes, A.; Lee, H. J.; Santoro, A.; Zinzani, P. L.; Timmerman, J.; Ramchandren, R.; Cohen, J.; De Boer, J. P.; Savage, K.; Kuruvilla, J.; Trnĕný, M.; Shipp, M.; Sacchi, M.; Sumbul, A.; Ansell, S. |
| Abstract Title: | Nivolumab for relapsed or refractory classical Hodgkin lymphoma after autologous haematopoietic cell transplantation: Extended follow-up of the phase 2 multi-cohort CheckMate 205 study |
| Meeting Title: | 59th Annual Scientific Meeting of the British Society for Hematology |
| Keywords: | hodgkin lymphoma; long-term outcomes; programmed; checkpoint inhibitor; death-1 |
| Journal Title: | British Journal of Haematology |
| Volume: | 185 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Apr 1-3 |
| Meeting Location: | Glasgow, UK |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2019-03-01 |
| Start Page: | 80 |
| End Page: | 81 |
| Language: | English |
| ACCESSION: | WOS:000462529200119 |
| PROVIDER: | wos |
| PUBMED: | 30916380 |
| DOI: | 10.1111/bjh.15854 |
| Notes: | Meeting Abstract: BSH19-PO-080 -- Source: Wos |
